BIVDA Press Releases

23Nov

All Party Parliamentary Group to raise the profile of the UK Life Sciences sector

23rd November 2018

This week marked the relaunch of the All Party Parliamentary Group (APPG) for Life Sciences. Chaired by Daniel Zeichner MP, the APPG will raise awareness of UK life sciences among parliamentarians and explore the challenges and opportunities facing the sector.

At its first meeting, held on Wednesday 21st November, the APPG considered the use of genome-editing technologies in healthcare and how these should be regulated. It explored the challenges of developing an oversight system that installs public confidence in emerging technologies while allowing new innovations and cutting-edge research to flourish. Leading industry experts from the Nuffield Council for Bioethics, law firm Fieldfisher and Spanish biotech SME, ZeClinics spoke at the meeting, which was attended by members of the European life sciences community as well as MPs and members of the House of Lords.

Commenting on the re-launch, Daniel Zeichner MP said: “I am delighted to Chair this APPG which will be an extremely important forum for making parliamentarians aware of the valuable contribution the UK life sciences sector makes to the nation’s health and wealth. Over the next year, the APPG will consider how we can support the sector and how we can make sure that our constituents, and society more broadly, benefit from the exciting new technologies and treatments being researched and developed by life science companies across the UK.”

Notes to editors

At the APPG’s AGM, also held on Wednesday 21st November, the following were elected as Officers:

  • Daniel Zeichner MP - Chair
  • Chris Green MP - Vice-Chair
  • Lord Warner - Officer
  • Lord Turnberg - Officer 
  • Lord Patel - Officer

The Association of the British Pharmaceutical Industry (ABPI) the BioIndustry Association (BIA) and the British In Vitro Diagnostics Association (BIVDA) jointly provide the secretariat for the APPG for Life Sciences.

For more information click here or email lifesciencesAPPG@bioindustry.org 

Related

NHS could save nearly £7 billion through quick adoption of new diagnostic techniques

London, UK – Research commissioned by Innovate UK and the British In Vitro Diagnostics Association ...

Read More >

BIVDA Response to 2017 Budget

The Chancellor of the Exchequer has today (22 November) delivered the Government’s 2017 Budget.

Read More >

MedTech Week: showcasing life-changing technologies across Europe

For the fourth year running, MedTech Week is bringing together medtech companies and national associ...

Read More >

BIVDA’s Response to the 2017 General Election Result

Commenting on the result of the Election, BIVDA’s Chief Executive Doris-Ann Williams MBE said: “...

Read More >

BIVDA Welcomes AAR Funding Announcement

Commenting on the Government’s announcement today (14 July 2017) regarding funding for the Accelera...

Read More >

BIVDA Launches Vision for Increasing Access to Molecular Diagnostics

A new report from the British In Vitro Diagnostics Association (BIVDA) has called for NHS England to...

Read More >